DrugPatentWatch Database Preview

Litigation Details for Pentech Phar Inc v. Par Phar Inc (N.D. Ill. 2004)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

Docket	Start Trial	Date Filed	2004-05-03
Court	District Court, N.D. Illinois	Date Terminated	2009-02-09
Cause	28:1332 Diversity-Breach of Contract	Assigned To	Honorable Morton Denlow
Jury Demand	Both	Referred To
Parties	PAR PHARMAECUTICAL, INC.; PENTECH PHARMACEUTICALS, INC.
Patents	4,721,723; 6,080,759
Attorneys	Eric Neal Macey; Evan R. Chesler; James Jerome Hartzell; John F. Shonkwiler; Kedric L. Payne; Matthew S. Miller; Michael P Burke; Michael Thomas Layden; Patrick A. Fleming; Rajeev K Adlakha; Richard A. Edlin; Richard J. Prendergast; Roger G. Brooks; Stephen V. Potenza; Vincent Michael Roche
Firms	Cravath, Swaine & Moore LLP; Greenberg Traurig LLP; Hartzell and Whiteman; Law Offices of Matthew S. Miller; Novack & MacEy; Novack and MacEy, LLP; Richard J. Prendergast, Ltd.
Link to Docket	External link to docket

The small molecule drugs covered by the patents cited in this case are Start Trial and Start Trial .

Subscribe to access the full database, or Start Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2009-02-09	295	memorandum opinion and order	alleged that it was the owner of a patent (Patent Nos. 4,721,723 and 6,080,759), and, in each case, … infringe GSK’s paroxetine patents. In 1997, Pentech was awarded a patent for a paroxetine composition…submitted applications for two additional patents on paroxetine, and patents on these applications were ultimately…one of GSK’s patents that was due to expire in 2006, and further admitted that the patents were valid …treatment of depression, among other things. GSK owns patent rights concerning Paxil. Paxil was approved by	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document